Compare LENZ & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | REPX |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.5M | 587.9M |
| IPO Year | 2021 | N/A |
| Metric | LENZ | REPX |
|---|---|---|
| Price | $13.04 | $27.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $56.25 | $36.00 |
| AVG Volume (30 Days) | ★ 1.1M | 278.2K |
| Earning Date | 03-18-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 5.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.07 |
| Revenue | $17,500,000.00 | ★ $397,398,000.00 |
| Revenue This Year | N/A | $0.59 |
| Revenue Next Year | $194.79 | $14.96 |
| P/E Ratio | ★ N/A | $6.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.48 | $21.98 |
| 52 Week High | $50.40 | $36.18 |
| Indicator | LENZ | REPX |
|---|---|---|
| Relative Strength Index (RSI) | 31.24 | 48.72 |
| Support Level | $12.48 | $26.35 |
| Resistance Level | $21.80 | $29.19 |
| Average True Range (ATR) | 1.22 | 1.13 |
| MACD | -0.24 | -0.13 |
| Stochastic Oscillator | 9.43 | 34.51 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.